West Virginia, Mississippi, and Arkansas are the U.S. states with the highest percentage of their population who are obese. The states with the lowest percentage of their population who are obese include Colorado, Hawaii, and Massachusetts. Obesity in the United States Obesity is a growing problem in many countries around the world, but the United States has the highest rate of obesity among all OECD countries. The prevalence of obesity in the United States has risen steadily over the previous two decades, with no signs of declining. Obesity in the U.S. is more common among women than men, and overweight and obesity rates are higher among African Americans than any other race or ethnicity. Causes and health impacts Obesity is most commonly the result of a combination of poor diet, overeating, physical inactivity, and a genetic susceptibility. Obesity is associated with various negative health impacts, including an increased risk of cardiovascular diseases, certain types of cancer, and diabetes type 2. As of 2022, around 8.4 percent of the U.S. population had been diagnosed with diabetes. Diabetes is currently the eighth leading cause of death in the United States.

In 2021-2022, Mississippi topped the ranking of states with the highest share of children/adolescents between 6 and 17 years of age who were obese. This statistic illustrates the obesity rates among children/adolescents between 6 and 17 years of age in the United States in 2021-2022, by state.

In 2023, approximately 40 percent of men in West Virginia were obese, the highest share of any state in the United States. This statistic presents the states with the highest share of men who were obese with a body mass index (BMI) of 30 or higher in the U.S. in 2023.

The adult obesity rate, or the percentage of the county population (age 18 and older*) that is obese, or has a Body Mass Index (BMI) equal to or greater than 30 [kg/m2], is illustrative of a serious health problem, in Champaign County, statewide, and nationally.

The adult obesity rate data shown here spans from Reporting Years (RY) 2015 to 2024. Champaign County’s adult obesity rate fluctuated during this time, peaking in RY 2022. The adult obesity rates for Champaign County, Illinois, and the United States were all above 30% in RY 2024, but the Champaign County rate was lower than the state and national rates. All counties in Illinois had an adult obesity rate above 30% in RY 2024, but Champaign County's rate is one of the lowest among all Illinois counties.

Obesity is a health problem in and of itself, and is commonly known to exacerbate other health problems. It is included in our set of indicators because it can be easily measured and compared between Champaign County and other areas.

This data was sourced from the University of Wisconsin’s Population Health Institute’s and the Robert Wood Johnson Foundation’s County Health Rankings & Roadmaps. Each year’s County Health Rankings uses data from the most recent previous years that data is available. Therefore, the 2024 County Health Rankings (“Reporting Year” in the table) uses data from 2021 (“Data Year” in the table). The survey methodology changed in Reporting Year 2015 for Data Year 2011, which is why the historical data shown here begins at that time. No data is available for Data Year 2018. The County Health Rankings website notes to use caution if comparing RY 2024 data with prior years.

*The percentage of the county population measured for obesity was age 20 and older through Reporting Year 2021, but starting in Reporting Year 2022 the percentage of the county population measured for obesity was age 18 and older.

Source: University of Wisconsin Population Health Institute. County Health Rankings & Roadmaps 2024. www.countyhealthrankings.org.

Obesity has become a major concern for health officials in the United States. Rates of obesity are higher than ever before and as a result, consequential medical conditions have arisen in those who suffer from obesity; while at the same time, medical expenses are skyrocketing for these same individuals. In this study, I analyze regional trends in the United States of both obesity rates and walkability in 74 cities in the United States. After analyzing the data and constructing visual representations, I found that the Northeast region of the US is most walkable, while the Southeast and Southwestern regions are the least walkable. In regards to obesity rates, I found that the West had the lowest obesity rates in both 2010 and 2013, while the Midwest and the Southeast had a high obesity rate in both 2010 and 2013. Additionally, the Northeastern US had a high obesity rate in 2013.

Quality of life is a measure of comfort, health, and happiness by a person or a group of people. Quality of life is determined by both material factors, such as income and housing, and broader considerations like health, education, and freedom. Each year, US & World News releases its “Best States to Live in” report, which ranks states on the quality of life each state provides its residents. In order to determine rankings, U.S. News & World Report considers a wide range of factors, including healthcare, education, economy, infrastructure, opportunity, fiscal stability, crime and corrections, and the natural environment. More information on these categories and what is measured in each can be found below:

Healthcare includes access, quality, and affordability of healthcare, as well as health measurements, such as obesity rates and rates of smoking. Education measures how well public schools perform in terms of testing and graduation rates, as well as tuition costs associated with higher education and college debt load. Economy looks at GDP growth, migration to the state, and new business. Infrastructure includes transportation availability, road quality, communications, and internet access. Opportunity includes poverty rates, cost of living, housing costs and gender and racial equality. Fiscal Stability considers the health of the government's finances, including how well the state balances its budget. Crime and Corrections ranks a state’s public safety and measures prison systems and their populations. Natural Environment looks at the quality of air and water and exposure to pollution.

In Mississippi, over ***** out of ten adults were reported to be either overweight or obese in 2018, making it the leading U.S. state that year. Other prominent states, in terms of overweight and obesity, included Arkansas in ******, Oklahoma in *******, and Louisiana in ***** place.

Corpulence per state

When it comes to obesity, specifically, percentages were still very high for certain states. Almost forty percent of West Virginia’s population was obese in 2018. Colorado, Hawaii, and California were some of the healthier states that year, with obesity rates between ** and ** percent. The average for the country itself stood at just over ** percent.

Obesity-related health problems

Being obese can lead to various health-related complications, such as diabetes and diseases of the heart. In 2017, almost ** people per 100,000 died of diabetes mellitus in the United States. In the same year, roughly *** per 100,000 Americans died of heart disease. While the number of deaths caused by heart disease has decreased significantly over the past sixty to seventy years, it is still one of the leading causes of death in the country.

United States US: Prevalence of Overweight: Weight for Height: Female: % of Children Under 5 data was reported at 6.900 % in 2012. This records an increase from the previous number of 6.400 % for 2009. United States US: Prevalence of Overweight: Weight for Height: Female: % of Children Under 5 data is updated yearly, averaging 6.900 % from Dec 1991 (Median) to 2012, with 6 observations. The data reached an all-time high of 8.700 % in 2005 and a record low of 5.100 % in 1991. United States US: Prevalence of Overweight: Weight for Height: Female: % of Children Under 5 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of overweight, female, is the percentage of girls under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's new child growth standards released in 2006.; ; World Health Organization, Global Database on Child Growth and Malnutrition. Country-level data are unadjusted data from national surveys, and thus may not be comparable across countries.; Linear mixed-effect model estimates; Estimates of overweight children are also from national survey data. Once considered only a high-income economy problem, overweight children have become a growing concern in developing countries. Research shows an association between childhood obesity and a high prevalence of diabetes, respiratory disease, high blood pressure, and psychosocial and orthopedic disorders (de Onis and Blössner 2003). Childhood obesity is associated with a higher chance of obesity, premature death, and disability in adulthood. In addition to increased future risks, obese children experience breathing difficulties and increased risk of fractures, hypertension, early markers of cardiovascular disease, insulin resistance, and psychological effects. Children in low- and middle-income countries are more vulnerable to inadequate nutrition before birth and in infancy and early childhood. Many of these children are exposed to high-fat, high-sugar, high-salt, calorie-dense, micronutrient-poor foods, which tend be lower in cost than more nutritious foods. These dietary patterns, in conjunction with low levels of physical activity, result in sharp increases in childhood obesity, while under-nutrition continues

The prevalence of obesity in the United States has risen gradually over the past decade. As of 2023, around ** percent of the population aged 18 years and older was obese. Obesity is a growing problem in many parts of the world, but is particularly troubling in the United States. Obesity in the United States The states with the highest prevalence of obesity are West Virginia, Mississippi, and Arkansas. As of 2023, a shocking ** percent of the population in West Virginia were obese. The percentage of adults aged 65 years and older who are obese has grown in recent years, compounding health issues that develop with age. Health impacts of obesity Obesity is linked to several negative health impacts including cardiovascular disease, diabetes, and certain types of cancer. Unsurprisingly, the prevalence of diagnosed diabetes has increased in the United States over the years. As of 2022, around *** percent of the population had been diagnosed with diabetes. Some of the most common types of cancers caused by obesity include breast cancer in postmenopausal women, colon and rectum cancer, and corpus and uterus cancer.

In 2022, over 33 percent of both men and women in the United States reported themselves as obese (BMI over 30), making it the country with the highest percentage of obese adults on this list. Other selected countries on the list with a high prevalence of obesity among adults included the United Kingdom and Australia. Obesity groups in the United States In 2022, Black adults had the highest overweight and obesity rates of any race or ethnicity in the United States. Asians and Native Hawaiians or Pacific Islanders had the lowest rates by far, with roughly 14 percent. In 2021, about 30 percent of people aged 65 and older were obese in the United States. This estimate has been steadily increasing since 2013 when roughly 27 percent of elderly Americans were obese. Leading health problems worldwide Obesity was considered one of 2023’s biggest health problems: 25 percent of adults worldwide stated that obesity was the biggest health issue for people within their country. Around 44 percent of adults stated that mental health was the most significant problem facing their country that year.

Obese Patient Trolley Market Outlook

The global market size for obese patient trolleys is projected to grow significantly from $350 million in 2023 to approximately $600 million by 2032, exhibiting a robust CAGR of 6.3%. The increasing prevalence of obesity, coupled with the rising demand for specialized medical equipment to ensure the safe transport of obese patients, is driving this market's growth. Innovations in trolley design and materials, coupled with increased healthcare spending, are also contributing factors to this upward trend.

The significant growth in the obese patient trolley market can be attributed to a myriad of factors. Primarily, the rising incidence of obesity worldwide has necessitated the need for specialized medical equipment. According to the World Health Organization (WHO), obesity has nearly tripled since 1975, with over 650 million adults classified as obese in 2016. This alarming trend has led to an increased demand for obese patient trolleys, which are specifically designed to safely transport overweight and obese patients, ensuring their comfort and reducing the risk of injury to both the patient and healthcare providers. The growing awareness and emphasis on patient safety and mobility have further accentuated the need for these specialized trolleys.

Technological advancements and innovations in the design of obese patient trolleys are another critical growth factor. Modern trolleys are equipped with features such as electric and hydraulic adjustment systems, advanced braking mechanisms, and enhanced weight-bearing capacities. These innovations not only improve the safety and comfort of obese patients but also enhance the efficiency and ease of use for healthcare providers. Additionally, the integration of lightweight yet durable materials, such as high-grade aluminum and stainless steel, has resulted in trolleys that are both robust and easy to maneuver. These advancements have led to increased adoption of obese patient trolleys across various healthcare settings, further driving market growth.

Moreover, the increased healthcare expenditure and the growing number of healthcare facilities globally are contributing to the market's expansion. Governments and private healthcare providers are investing heavily in modernizing their medical infrastructure to cater to the needs of an increasingly obese population. This includes the procurement of specialized medical equipment such as obese patient trolleys. Additionally, the rise in the number of bariatric surgeries and other medical procedures that require the safe transport of obese patients is further fueling the demand for these trolleys. The growing focus on enhancing patient care and safety standards is expected to continue driving market growth in the coming years.

Analyzing the regional outlook, North America is expected to remain the dominant market for obese patient trolleys, largely due to the high prevalence of obesity and the advanced healthcare infrastructure in the region. The United States, in particular, has one of the highest obesity rates globally, which has led to a significant demand for specialized medical equipment. Europe is also anticipated to witness substantial growth, driven by the increasing focus on patient safety and the rising investments in healthcare infrastructure. The Asia Pacific region is projected to exhibit the highest CAGR, primarily due to the growing healthcare expenditure, the rising incidence of obesity, and the increasing adoption of advanced medical technologies in countries such as China and India.

In the context of specialized medical equipment, the Overweight Patient Tilt Table emerges as a crucial innovation for healthcare providers. This equipment is designed to safely and effectively manage the positioning and movement of overweight patients, particularly in scenarios where precise positioning is critical, such as during diagnostic procedures or rehabilitation sessions. The tilt table offers adjustable angles and secure support, ensuring patient comfort and safety while minimizing the risk of injury to both patients and healthcare staff. As the prevalence of obesity continues to rise, the demand for such specialized equipment is expected to grow, highlighting the importance of integrating advanced solutions like the Overweight Patient Tilt Table into healthcare settings.

Product Type Analysis

The obese patient trolley market can be segmented into three primary product types: manual trolleys, electric

Obese Patient Care System Market Outlook

The global market size for Obese Patient Care Systems was estimated to be around USD 3.2 billion in 2023, with a Compound Annual Growth Rate (CAGR) of approximately 7.5% expected to drive the market to an estimated USD 6.4 billion by 2032. One of the key growth factors for this market includes the rising prevalence of obesity worldwide, which necessitates specialized equipment and systems to manage the unique healthcare needs of obese patients.

One of the primary growth factors for the obese patient care system market is the increasing prevalence of obesity globally. According to the World Health Organization (WHO), the number of obese individuals has tripled since 1975. As obesity is associated with various comorbidities such as diabetes, cardiovascular diseases, and musculoskeletal disorders, the need for specialized healthcare systems to cater to this demographic has become imperative. This trend is creating a sustained demand for obese patient care systems, ranging from beds and wheelchairs to specialized scales and lifts.

Technological advancements are another significant growth factor contributing to the expansion of the obese patient care system market. Innovations in medical devices, such as advanced bariatric beds with integrated monitoring systems and automated wheelchairs, are enhancing patient comfort and care efficiency. Manufacturers are increasingly focusing on developing user-friendly, durable, and multifunctional equipment that can withstand higher weights while ensuring safety. These technological improvements are making it easier for healthcare providers to deliver optimal care to obese patients, thereby driving market growth.

Government initiatives and policies aimed at combating obesity and improving healthcare infrastructure are also playing a crucial role in market expansion. Various countries are investing in healthcare facilities and programs to manage obesity more effectively. These initiatives often include funding for specialized equipment and training for healthcare providers, which in turn bolsters the demand for obese patient care systems. For instance, government grants and subsidies for hospitals to purchase bariatric equipment can significantly impact market growth.

In terms of regional outlook, North America is expected to dominate the obese patient care system market, followed by Europe and the Asia Pacific. The high prevalence of obesity in North America, particularly in the United States, along with well-established healthcare infrastructure, contributes to this dominance. Europe also shows significant potential due to rising obesity rates and increased healthcare spending. The Asia Pacific region, with its growing healthcare infrastructure and increasing awareness about obesity management, is anticipated to witness the highest growth rate during the forecast period.

Product Type Analysis

The product type segment of the obese patient care system market includes beds, lifts, scales, wheelchairs, commodes, and others. Each of these product types serves a unique role in managing and providing care for obese patients, making them indispensable in various healthcare settings. Among these, bariatric beds are one of the most crucial components, designed to accommodate higher weight capacities while providing comfort and safety. These beds often come with advanced features such as electric adjustments, integrated scales, and specialized mattresses to prevent pressure sores, making them highly sought after in hospitals and home care settings.

Lifts are another essential product type within the obese patient care system market. These devices are designed to assist in the safe and efficient transfer of obese patients, thereby reducing the risk of injury to both patients and healthcare providers. Modern lifts often come with advanced features like motorized operation, remote control, and multi-functional slings, enhancing their usability and effectiveness. The increasing focus on patient safety and comfort is driving the demand for advanced lift systems.

Scales specifically designed for obese patients are crucial for monitoring weight and managing overall health. These scales often have higher weight capacities and larger platforms compared to standard scales, ensuring accurate measurements for obese individuals. Some advanced models also offer digital readouts, wireless connectivity, and integration with electronic health records (EHR) systems, enhancing their utility in clinical settings. The growing emphasis on monitoring and managing obesity-related hea

In 2022, the highest incidence of obesity-associated cancer in the United States was among Black individuals, with a rate of 184 per 100,000 people. This graph shows the rate of obesity-related cancers per 100,000 people in the United States in 2022, by race and ethnicity.

In 2022, postmenopausal breast cancer was the type of obesity-associated cancer with the highest incidence in the United States, with a rate of approximately 355 per 100,000 people. This graph shows the rate of obesity-related cancers per 100,000 people in the United States in 2022, by cancer type.

In 2021, almost 19 percent of high school students in Georgia were overweight. This statistic depicts the share of overweight high school students in the United States in 2021, sorted by state.

Appetite Control Suppressants Market Outlook

The global appetite control suppressants market size was valued at approximately $4.5 billion in 2023, and it is projected to reach around $7.8 billion by 2032, exhibiting a CAGR of 6.2% during the forecast period. This robust growth can be attributed to increasing awareness of healthy lifestyles, rising obesity rates, and advancements in pharmaceutical formulations and delivery mechanisms.

One of the significant growth factors contributing to the expansion of the appetite control suppressants market is the increasing prevalence of obesity and overweight conditions worldwide. According to the World Health Organization (WHO), obesity has nearly tripled since 1975, with over 650 million adults classified as obese in 2023. This alarming rise in obesity has accelerated the demand for effective weight management solutions, including appetite suppressants. As more individuals seek to manage their weight through medical and natural interventions, the appetite suppressants market is poised for substantial growth.

Another critical factor driving the market growth is the growing consumer inclination towards health and wellness. Modern consumers are more health-conscious and proactive in managing their dietary habits and overall well-being. This shift in consumer behavior has led to an increased demand for dietary supplements, including appetite suppressants. Additionally, advancements in manufacturing technologies and the development of novel, more effective appetite suppressant formulations have made these products more accessible and appealing to a broader audience.

Technological advancements in the healthcare and pharmaceutical industries are also fueling the growth of the appetite control suppressants market. The integration of innovative technologies, such as advanced drug delivery systems and personalized medicine, has improved the efficacy and safety profiles of appetite suppressants. Furthermore, research and development activities focusing on identifying new active ingredients and optimizing existing formulations are expected to create new opportunities for market expansion.

Regionally, North America holds a dominant position in the appetite control suppressants market, primarily due to the high prevalence of obesity and the presence of key market players in the region. The United States, in particular, has one of the highest obesity rates globally, which has driven the demand for weight management products. Moreover, the region's advanced healthcare infrastructure and favorable regulatory environment support the growth of the market. Europe and Asia Pacific are also significant markets, with Europe experiencing steady growth and Asia Pacific expected to witness the highest CAGR during the forecast period, driven by increasing health awareness and rising disposable incomes.

Product Type Analysis

The appetite control suppressants market can be segmented by product type into prescription appetite suppressants, over-the-counter (OTC) appetite suppressants, and natural appetite suppressants. Prescription appetite suppressants are formulations that require a doctor's prescription and are typically used under medical supervision. These products are usually more potent and are prescribed to individuals with significant weight management issues. The demand for prescription appetite suppressants is driven by the increasing number of obesity cases and the rising awareness of the health risks associated with obesity.

Over-the-counter appetite suppressants, on the other hand, are available without a prescription and are widely accessible to consumers. These products are often marketed as dietary supplements and are popular among individuals seeking to manage their weight without medical intervention. The market for OTC appetite suppressants is expanding rapidly due to their ease of access, relatively lower cost, and growing consumer preference for self-managed weight loss solutions. These products often contain natural ingredients, which are perceived as safer by consumers, further driving their popularity.

Natural appetite suppressants include products derived from herbal and botanical sources that are believed to aid in weight management by reducing appetite naturally. The increasing trend towards organic and natural products has significantly boosted the demand for natural appetite suppressants. Consumers are becoming more inclined towards natural health products due to the perceived lower risk of side effects and the overall trend of adopting a more natural and holistic approac

BackgroundAlthough most countries face increasing population levels of obesity and diabetes their effect on coronary heart disease (CHD) mortality has not been often studied in small island developing states (SIDs) where obesity rates are among the highest in the world. We estimated the relative contributions of treatments and cardiovascular risk factors to the decline in CHD mortality from 1990 to 2012 in the Caribbean island, Barbados.MethodsWe used the IMPACT CHD mortality model to estimate the effect of increased coverage of effective medical/surgical treatments and changes in major CHD risk factors on mortality trends in 2012 compared with 1990. We calculated deaths prevented or postponed (DPPs) for each model risk factor and treatment group. We obtained data from WHO Mortality database, population denominators from the Barbados Statistical Service stratified by 10-year age group (ages 25–34 up to 85 plus), population-based risk factor surveys, Global Burden of Disease and Barbados’ national myocardial infarction registry. Monte Carlo probabilistic sensitivity analysis was performed.ResultsIn 1990 the age-standardized CHD mortality rate was 109.5 per 100,000 falling to 55.3 in 2012. Implementation of effective treatment accounted for 56% DPPs (95% (Uncertainty Interval (UI) 46%, 68%), mostly due to the introduction of treatments immediately after acute myocardial infarction (AMI) (14%) and unstable angina (14%). Overall, risk factors contributed 19% DPPs (95% UI 6% to 34%) mostly attributed to decline in cholesterol (18% DPPs, 95% UI 12%, 26%). Adverse trends in diabetes: 14% additional deaths(ADs) 95% UI 8% to 21% ADs) and BMI (2% ADs 95%UI 0 to 5% ADs) limited potential for risk factor gains.ConclusionsGiven the significant negative impact of obesity/diabetes on mortality in this analysis, research that explores factors affecting implementation of evidenced-based preventive strategies is needed. The fact that most of the decline in CHD mortality in Barbados was due to treatment provides an example for SIDs about the advantages of universal access to care and treatment.

Overweight Patient Tilt Table Market Outlook

The global overweight patient tilt table market size is projected to grow from USD 500 million in 2023 to USD 750 million by 2032, registering a compound annual growth rate (CAGR) of 4.5% during the forecast period. The primary growth factors for this market include the increasing prevalence of obesity and related health complications, advancements in medical technology, and rising awareness about the benefits of tilt table therapy for overweight patients.

One of the significant growth drivers for the overweight patient tilt table market is the rising incidence of obesity worldwide. The World Health Organization (WHO) estimates that obesity has nearly tripled since 1975, with over 650 million adults classified as obese in 2016. This increase in obesity rates has led to a higher demand for specialized medical equipment, such as tilt tables, to assist in the treatment and rehabilitation of overweight patients. Additionally, the growing awareness of the health risks associated with obesity, including cardiovascular diseases, diabetes, and musculoskeletal disorders, has further fueled the demand for tilt tables.

Advancements in medical technology have also played a crucial role in driving the growth of the overweight patient tilt table market. Innovations in tilt table design and functionality, such as motorized tilt tables with enhanced safety features and adjustable settings, have made these devices more effective and user-friendly. These advancements have improved patient outcomes and increased the adoption of tilt tables in various healthcare settings. Furthermore, the integration of digital monitoring systems and data analytics in modern tilt tables has enabled healthcare providers to track patient progress and tailor treatment plans more effectively.

The increasing focus on rehabilitation and physiotherapy for overweight patients is another key factor contributing to the market's growth. Tilt table therapy has been proven to offer numerous benefits for obese patients, including improved circulation, enhanced muscle strength, and better postural control. As a result, there has been a growing recognition of the importance of incorporating tilt table therapy into comprehensive treatment plans for overweight patients. This has led to a higher demand for tilt tables in rehabilitation centers, hospitals, and clinics worldwide.

In addition to tilt tables, the use of specialized equipment like the Overweight Patient Wheelchair has become increasingly important in the healthcare sector. These wheelchairs are designed to accommodate the unique needs of overweight patients, offering enhanced support and comfort. They are equipped with features such as reinforced frames, wider seats, and adjustable components to ensure safety and ease of mobility for patients with higher body weights. As the prevalence of obesity continues to rise, the demand for such specialized wheelchairs is expected to grow, providing essential assistance in both clinical and home settings. The integration of these wheelchairs into patient care plans not only improves mobility but also enhances the overall quality of life for overweight individuals.

Regionally, North America holds the largest share of the overweight patient tilt table market, driven by the high prevalence of obesity in the region and the presence of advanced healthcare infrastructure. The United States, in particular, has one of the highest obesity rates globally, with the Centers for Disease Control and Prevention (CDC) reporting that nearly 42.4% of American adults were obese in 2017-2018. This has resulted in a significant demand for specialized medical equipment, including tilt tables, to cater to the needs of overweight patients. Additionally, the availability of government funding and supportive healthcare policies in North America further supports market growth.

Product Type Analysis

In the overweight patient tilt table market, product type is a crucial segment that includes manual tilt tables and motorized tilt tables. Manual tilt tables are typically operated using a lever or crank mechanism, allowing healthcare providers to control the table's tilt angle manually. These tables are relatively cost-effective and do not require an external power source, making them suitable for use in various healthcare settings, including clinics and smaller hospitals. However, manual tilt tables may require more physical effort to operate and may not offer the sam

In 2021, the State of Mexico was the region with the highest prevalence of overweight in Mexico, reaching approximately **** percent of interviewed adults aged 20 years or older. Mexico City and the South Pacific region followed, both with an overweight prevalence among adults of about **** percent. Meanwhile, for obesity, the highest prevalence was reported in the Border region, where more than four in every ten people were suffering from obesity or had a body mass index (BMI) equal to or larger than ** kg/m². Obesity was more common among women than men in Mexico as of that year.

BackgroundInfertility is a public health issue closely related to obesity. However, the relationship between obesity-related indicators and infertility is currently uncertain. The present study aimed to explore the association between obesity-related indicators and female infertility.MethodsThis cross-sectional study included data for 2,875 adult females aged 20–45 years from the National Health and Nutrition Examination Survey conducted between 2013 and 2018. Logistic regression models, restricted cubic spline (RCS), and receiver operating characteristic (ROC) analyses were used to evaluate the relationship between obesity-related indicators [body shape index (ABSI), weight-adjusted waist index (WWI), body roundness index (BRI), waist-to-height ratio (WHtR), non-HDL cholesterol to HDL cholesterol ratio (NHHR), relative fat mass (RFM), body mass index (BMI), and waist circumference (WC)] and female infertility.ResultsAdult females were divided into five groups based on their ABSI, WWI, BRI, WHtR, NHHR, RFM, BMI, and WC. Individuals in the highest quintile for ABSI, WWI, BRI, WHtR, NHHR, RFM, BMI, and WC had a higher risk of infertility compared to those in the lowest quintile. The respective adjusted odds ratio values were 1.65 (95% confidence interval (CI), 1.14 to 2.42), 1.71 (95% CI, 1.15 to 2.57), 2.09 (95% CI, 1.39 to 3.19), 2.09 ( 95% CI, 1.39 to 3.19), 1.71 (95% CI, 1.14 to 2.59), 2.09 (95% CI, 1.39 to 3.19), 2.10 (95% CI, 1.40 to 3.18), and 2.28 (95% CI, 1.52 to 3.47). The p for trend values were 0.027,